World Health Organization site
Skip Navigation Links
Home
Advanced Search
List ByExpand List By
Search Tips
UTNExpand UTN
ICTRP websiteExpand ICTRP website
Contact us
                   94 records for 26 trials found!
Trials are sometimes recorded in more than one registry. These records can refer to each other using the 'Secondary ID' field. The search portal uses these Secondary IDs to group records about the same trial together in the search results.
Each group of records referring to a trial is displayed in table that is seen by pressing the + symbol. The record with the earliest date of registration is always shown first.
 
 
 
 
  Showrecords per page     

1 2 3
Recruitment statusMain ID Public TitleDate of Registration
AuthorisedEUCTR2013-000324-34-PL
A research study to assess whether lorcaserin HCl affects the risk of developing cardiovascular diseases in obese or overweight men and women at higher risk of developing these diseases 07/07/2014
RecruitingNCT02148302
Clinical Trial to Evaluate Blister Graft Utilizing a Novel Harvesting Device for Treatment of Venous Leg Ulcers
27/01/2014
Not recruitingNCT02019264
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors 18/12/2013
Not RecruitingEUCTR2012-003507-35-ES
A study of tivozanib hydrochloride plus paclitaxel versus placebo plus paclitaxel in the treatment of breast cancer 09/04/2013
Not recruitingNCT01745367
Tivozanib Hydrochloride in Combination With Paclitaxel Versus Placebo With Paclitaxel in Patients With Locally Recurrent or Metastatic Triple Negative Breast Cancer 06/12/2012
Not recruitingNCT01706861
A Post Market Study Evaluating the Safety, Device Perfomance and Possible Emergent Risks of Celotres in Preventing Recurrence in Keloid Lesions Treated Adjunctive to Surgical Excision
03/10/2012
 PER-005-12
AN OPEN-LABEL, SINGLE-ARM, EXTENSION STUDY TO DEMONSTRATE LONG-TERM EFFICACY AND SAFETY OF CT-P13 WHEN CO-ADMINISTERED WITH METHOTREXATE IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO WERE TREATED WITH INFLIXIMAB (REMICADE OR CT-P13) IN STUDY CT-P13 3.1.
29/05/2012
Not recruitingNCT01446770
Evaluation of the Initial Safety and Efficacy of Keloid Lesions Treated With MF-4181
02/10/2011
AuthorisedEUCTR2011-000198-29-ES
A study in women with advanced breast cancer treated with standard therapy with or without MEDI-573 09/08/2011
AuthorisedEUCTR2009-017905-13-ES
Ensayo de Fase III, multicéntrico, de 3 brazos, aleatorizado, para evaluar la eficacia y seguridad de T-DM1 en combinación con pertuzumab ó T-DM1 en combinación con placebo de pertuzumab (ciego para pertuzumab), frente a la combinación de trastuzumab más taxano, como tratamiento de primera línea en pacientes con cáncer de mama en progresión, o avanzado localmente recurrente o metastásico, HER2-positivo. A randomized, 3 arm, multicentre, phase III study to evaluate the efficacy and the safety of T-DM1 combined with pertuzumab or T-DM1 combined with pertuzumab-placebo (blinded for pertuzumab), versus the combination of trastuzumab plus taxane, as first line treatment in HER2- positive progressive or recurrent locally advanced or metastatic breast cancer (MBC).
Recruitment statusMain IDPublic titleDate of registration
AuthorisedEUCTR2009-017905-13-FRA randomized, 3 arm, multicentre, phase III study to evaluate the efficacy and the safety of T-DM1 combined with pertuzumab or T-DM1 combined with pertuzumab-placebo (blinded for pertuzumab), versus the combination of trastuzumab plus taxane, as first line treatment in HER2- positive progressive or recurrent locally advanced or metastatic breast cancer (MBC).11/05/2010
AuthorisedEUCTR2009-017905-13-ITA randomized, 3 arm, multicentre, phase III study to evaluate the efficacy and the safety of T-DM1 combined with pertuzumab or T-DM1 combined with pertuzumab-placebo (blinded for pertuzumab), versus the combination of trastuzumab plus taxane, as first line treatment in HER2- positive progressive or recurrent locally advanced or metastatic breast cancer (MBC). - ND16/07/2010
AuthorisedEUCTR2009-017905-13-GRA randomized, 3 arm, multicentre, phase III study to evaluate the efficacy and the safety of T-DM1 combined with pertuzumab or T-DM1 combined with pertuzumab-placebo (blinded for pertuzumab), versus the combination of trastuzumab plus taxane, as first line treatment in HER2- positive progressive or recurrent locally advanced or metastatic breast cancer (MBC).18/01/2011
Not recruitingNCT01120184A Study of Trastuzumab Emtansine (T-DM1) Plus Pertuzumab/Pertuzumab Placebo Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic Breast Cancer (MARIANNE)28/04/2010
AuthorisedEUCTR2009-017905-13-BEA Study of Trastuzumab-DM1 Plus Pertuzumab Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic Breast Cancer [MARIANNE] . 31/08/2010
AuthorisedEUCTR2009-017905-13-GBA Study of Trastuzumab-DM1 Plus Pertuzumab Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic Breast Cancer [MARIANNE] . 25/06/2010
AuthorisedEUCTR2009-017905-13-SEA Study of Trastuzumab-DM1 Plus Pertuzumab Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic Breast Cancer [MARIANNE] . 24/05/2010
AuthorisedEUCTR2009-017905-13-ATA Study of Trastuzumab-DM1 Plus Pertuzumab Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic Breast Cancer [MARIANNE] . 23/03/2010
AuthorisedEUCTR2009-017905-13-HUA Study of Trastuzumab-DM1 Plus Pertuzumab Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic Breast Cancer [MARIANNE] . 15/06/2010
AuthorisedEUCTR2009-017905-13-DKA Study of Trastuzumab-DM1 Plus Pertuzumab Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic Breast Cancer [MARIANNE] . 15/06/2010
AuthorisedEUCTR2009-017905-13-PTA Study of Trastuzumab-DM1 Plus Pertuzumab Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic Breast Cancer [MARIANNE] . 29/09/2010
Not RecruitingJPRN-JapicCTI-111487Phase III clinical trial of RG3502 and RG1273 for breast cancer patients01/10/2012
Not RecruitingEUCTR2009-017905-13-CZA Study of Trastuzumab-DM1 Plus Pertuzumab Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic Breast Cancer [MARIANNE] . 25/06/2010
Not RecruitingEUCTR2009-017905-13-DEA Study of Trastuzumab-DM1 Plus Pertuzumab Versus Trastuzumab [Herceptin] Plus a Taxane in Patients With Metastatic Breast Cancer [MARIANNE] . 06/04/2010
23/03/2010
    
1 2 3
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.2 - Version history